focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Regulatory News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Oct 2013 14:09

RNS Number : 7771Q
Akers Biosciences, Inc.
17 October 2013
 



 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Akers Biosciences Inc.

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

ü

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Robert Giles

4. Full name of shareholder(s)  (if different from 3.):iv

Robert Giles

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

13 September 2013

6. Date on which issuer notified:

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

CFD

17,950,000

6.42%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

17,950,000

6.42%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

 

 

14. Contact name:

Angela Fairs

15. Contact telephone number:

0207 818 2070

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGGMUUUPWGWM
Date   Source Headline
26th Nov 20099:28 amRNSHolding(s) in Company
25th Nov 20099:21 amRNSDirectorate Change
24th Nov 20097:00 amRNSHolding(s) in Company
4th Nov 20097:00 amRNSTrading Statement
30th Sep 20097:00 amRNSHalf Yearly Report
29th Sep 20097:00 amRNSABI Signs Malaria Test Distribution Agreement
13th Jul 20095:29 pmRNSResult of AGM
26th Jun 20099:19 amRNSAnnual Report & Accounts
25th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 20097:00 amRNSFinal Results
19th Mar 20093:26 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSNotice of Preliminary Results
8th Jan 20091:48 pmRNSGrant of Warrants - Replacement
8th Jan 200912:00 pmRNSGrant of Warrants
8th Jan 20097:00 amRNSTrading Update
5th Jan 20097:00 amRNSTechnology Transfer & Supply Agreement
3rd Dec 20087:00 amRNSABI Sells Tax Losses in State of NJ, USA
20th Nov 20087:00 amRNSU.S. Over-the-Counter Distribution Agreement
27th Oct 20087:00 amRNSDirectorate Change
16th Sep 20083:17 pmRNSDirector/PDMR Shareholding
8th Sep 20087:30 amRNSNew Diagnostics in Diabetes
8th Sep 20087:00 amRNSInterim Results
4th Aug 20087:00 amRNSNotice of First Half Results
14th Jul 20087:00 amRNSABI Licenses Lithium System
26th Jun 20087:00 amRNSABI Signs New Distribution Ag
12th Jun 20083:50 pmRNSPlacing Update
11th Jun 20087:00 amRNSAdditional Listing
4th Jun 20089:00 amRNSAnnual Report and Accounts
4th Jun 20087:00 amRNSOption Agreement
9th Apr 20087:00 amRNSDirector/PDMR Shareholding
7th Apr 20087:01 amRNSFinal Results
3rd Apr 20087:00 amRNSDirectorate Change
14th Mar 200811:31 amRNSIssue of Equity
14th Jan 200810:17 amRNSIssue of Equity
7th Jan 20084:20 pmRNSResolution of Litigation
20th Dec 20077:01 amRNSDirector/PDMR Shareholding
18th Dec 200712:01 pmRNSChange of Adviser
28th Sep 200710:41 amRNSTotal Voting Rights
28th Sep 20077:00 amPRNDirectors' Shareholdings & Additional Listing
27th Sep 20077:00 amPRNHalf-yearly Report
18th Sep 20077:00 amPRNUnited States Military Contract
17th Sep 20077:00 amPRNUnited States Military Contract
12th Sep 20077:00 amPRNUK Sales Agency Agreement
7th Sep 200712:52 pmRNSIssue of Equity
21st Aug 20075:07 pmRNSChange of Nominated Adviser
17th Aug 20072:04 pmRNSAIM Rule 26
9th Aug 20077:00 amPRNDirectorate Change
8th Aug 20076:24 pmPRNAGM Statement
2nd Aug 20077:00 amPRNNotice of Results
31st Jul 20079:22 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.